Diagnostics News and Research

RSS

Oliver Dowden: New Biothreats Radar will be key to the UK’s fight against future biological threats

A new Biothreats Radar capable of scanning biological risks that pose a threat to the public will be key to the UK's fight and preparation for future pandemics, the Deputy Prime Minister Oliver Dowden has announced today (Monday 12 June).

12 Jun 2023

Innovative 'village in a dish' system can accelerate stem cell research

A powerful new stem cell technique has enabled large-scale studies of the relationship between human genetics and biology.

9 Jun 2023

INTEGRA Biosciences’ pipettes help to combat prostate cancer

The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and turnaround times and, ultimately, support timely diagnosis and treatment.

From INTEGRA Biosciences 6 Jun 2023

Study of immunotherapy for brain cancer metastases shows promising results

In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving longer than two years.

2 Jun 2023

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis.

2 Jun 2023

Innovative approach for detecting pre-cancerous lesions using large, high-res images

A new study presents an innovative approach to the crucial detection of pre-cancerous lesions using large, high-res images.

1 Jun 2023

CSEM collaborates with innovative Swiss start-up MOMM diagnostics to introduce revolutionary preeclampsia test

CSEM’s Tools for Life Sciences team is partnering with MOMM Diagnostics to develop a cutting-edge point-of-care solution for preeclampsia diagnostics. This ground-breaking multiplexed sensing device simultaneously detects two crucial biomarkers associated with this prevalent disease.

From CSEM 31 May 2023

Health experts and multinationals join together to announce the formation of Movement Health Foundation

On the sidelines of the 76th World Health Assembly, Harvard University's Professor of Global Health Systems, Rifat Atun, the Copenhagen Institute for Future Studies (CIFS), Microsoft, Roche, and Siemens Healthineers came together to announce the formation of the Movement Health Foundation.

27 May 2023

Hydrogen sulfide can be used to support photothermal therapy for cancer

Hydrogen sulfide is usually a highly toxic gas. However, with careful preparation, it can be used to support photothermal therapy (PTT) in treating cancer, as a team of researchers reporting in the journal Angewandte Chemie has recently discovered.

26 May 2023

Large study uncovers new details about long COVID

Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the post-infection set of conditions that can affect nearly every tissue and organ in the body.

26 May 2023

Two bacteria that co-occur with C. difficile as emerging potential threats in planetary health

A new study published in the peer-reviewed OMICS: A Journal of Integrative Biology identified genes for virulence and antimicrobial resistance in two bacteria that co-occur with C. difficile, suggesting these pathogens as emerging potential threats in planetary health.

26 May 2023

Makeup of microbiome in a person's tumor varies depending on early or late-onset colorectal cancer

Researchers at Georgetown University's Lombardi Comprehensive Cancer Center studied the microbiome of people with colorectal cancer and found the make-up of the bacteria, fungi and viruses in a person's tumor varied significantly depending on whether they were diagnosed with early-onset disease (age 45 or younger) or late-onset disease (age 65 or older).

26 May 2023

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to this year's recipient of the Pittsburgh Analytical Chemistry Award, Neil Kelleher, about his work in top-down proteinomics.

From Pittcon 26 May 2023

Study sheds light on global disparities in mortality rates from liver disease

New research is shedding light on global disparities in mortality rates from late-stage liver disease, also called cirrhosis.

25 May 2023

Lupus Landmark Study launched to accelerate the development of personalized treatments for lupus patients

The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics today announced the launch of the Lupus Landmark Study, a groundbreaking observational research study to accelerate the development of personalized treatments for people living with lupus.

24 May 2023

CDC reports on its Mpox response

Research paper provides an overview of the U.S. monkeypox outbreak, highlighting the rapid response, vaccination efforts, and racial disparities in cases. Ongoing surveillance, vaccination, and communication are emphasized as crucial for future prevention.

24 May 2023

Wastewater surveillance reveals hidden scale of mpox rpidemic, challenging official figures

Research highlights the potential of wastewater-based epidemiology as a complementary tool to clinical monitoring for assessing the magnitude of a mpox epidemic. Findings suggest that the presence of mpox DNA in wastewater does not directly correspond to the number of hospitalizations, indicating the underestimation of the epidemic's scale and unidentified cases.

19 May 2023

Diagnostics News and Research

Oliver Dowden: New Biothreats Radar will be key to the UK’s fight against future biological threats

Innovative 'village in a dish' system can accelerate stem cell research

INTEGRA Biosciences’ pipettes help to combat prostate cancer

Study of immunotherapy for brain cancer metastases shows promising results

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Innovative approach for detecting pre-cancerous lesions using large, high-res images

CSEM collaborates with innovative Swiss start-up MOMM diagnostics to introduce revolutionary preeclampsia test

Health experts and multinationals join together to announce the formation of Movement Health Foundation

Hydrogen sulfide can be used to support photothermal therapy for cancer

Large study uncovers new details about long COVID

Two bacteria that co-occur with C. difficile as emerging potential threats in planetary health

Makeup of microbiome in a person's tumor varies depending on early or late-onset colorectal cancer

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

Study sheds light on global disparities in mortality rates from liver disease

Lupus Landmark Study launched to accelerate the development of personalized treatments for lupus patients

CDC reports on its Mpox response

Wastewater surveillance reveals hidden scale of mpox rpidemic, challenging official figures

Biosensor Versatility; From Analytical Chemistry to Diagnostics

UK’s first Centre for Phage Research highlights Actiphage in the KTN UK Phage Innovation Showcase

Roche partners with Social Value Portal to measure its social value impact on societies across the UK

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News